Ginkgo Bioworks and Boehringer Ingelheim team up for innovative treatments.

Ginkgo Bioworks has partnered with Boehringer Ingelheim to accelerate the discovery and development of novel therapeutic molecules to address diseases with high unmet patient needs that are out of reach of conventional drug discovery. The two companies will leverage Ginkgo's natural product discovery capabilities to mine Ginkgo's metagenomic sequence database, potentially enabling the rapid identification of lead molecules as starting points for the potential discovery of novel treatments to transform patients' lives.